Menu
GeneBe

MEFV

MEFV innate immunity regulator, pyrin, the group of Pyrin domain containing|Tripartite motif family

Basic information

Region (hg38): 16:3242026-3256633

Previous symbols: [ "MEF" ]

Links

ENSG00000103313NCBI:4210OMIM:608107HGNC:6998Uniprot:O15553AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • familial Mediterranean fever (Definitive), mode of inheritance: AR
  • familial Mediterranean fever (Supportive), mode of inheritance: AD
  • autosomal recessive familial Mediterranean fever (Definitive), mode of inheritance: AR
  • familial Mediterranean fever, autosomal dominant (Strong), mode of inheritance: AR
  • familial Mediterranean fever (Definitive), mode of inheritance: Semidominant

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Familial Mediterranean fever; Neutrophilic dermatosis, acute febrileAD/ARAllergy/Immunology/InfectiousIndividuals with Familial Mediterranean Fever may present with periodic fever, pain (including abdominal pain, arthritis, pleurisy), and rash,and medical treatment aimed at reducing inflammation (eg, with colchicine, TNF-alpha antibodies, IL-1 decoy receptor agents) can be effective (and additional considerations related to medical treatment prior to and during pregnancy may be beneficial); BMT has been reported; Individuals with Neutrophilic dermatosis, acute febrile have been described with pediatric onset of recurrent fever and dermatologic abnormalities, and treatment (eg, with corticosteroids, adalimumab, and TNFA antagonist) has been described as potentially beneficial but not completely effective.Allergy/Immunology/Infectious; Dermatologic; Musculoskeletal; Renal14162896; 4437392; 4636899; 4783424; 921085; 6822630; 3966749; 3306755; 3515182; 3694919; 8434621; 8831074; 9288094; 9288758; 9415347; 9266193; 9450890; 10528243; 10787449; 12130485; 12529300; 14679589; 15024744; 16632148; 20301405; 23075349; 23070486; 23463692; 23508419; 23505238; 23521609; 23710607; 23716950; 23742958; 23800337; 23844200; 27030597; 28835462; 31998953
It has been described that heterozygous mutations, while potentially contributing to/causing certain autoinflammatory disorders, do not cause classic (Mendelian) Familial Mediterranean fever, but may act as risk alleles (susceptibility factors) for clinically similar forms of disease

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MEFV gene.

  • Familial Mediterranean fever (894 variants)
  • not provided (286 variants)
  • Familial Mediterranean fever, autosomal dominant (223 variants)
  • Acute febrile neutrophilic dermatosis (187 variants)
  • not specified (166 variants)
  • Autoinflammatory syndrome (115 variants)
  • Inborn genetic diseases (73 variants)
  • Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant;Acute febrile neutrophilic dermatosis (69 variants)
  • Acute febrile neutrophilic dermatosis;Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant (59 variants)
  • Familial Mediterranean fever;Familial Mediterranean fever, autosomal dominant (21 variants)
  • MEFV-related condition (8 variants)
  • Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever;Acute febrile neutrophilic dermatosis (8 variants)
  • See cases (4 variants)
  • Acute febrile neutrophilic dermatosis;Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever (4 variants)
  • Behcet disease (2 variants)
  • 8 conditions (2 variants)
  • Heart, malformation of;Renal insufficiency;Abnormal cardiovascular system morphology (1 variants)
  • MEFV-related disorders (1 variants)
  • Recurrent fever (1 variants)
  • Central core myopathy (1 variants)
  • Neurodevelopmental delay;Skin vesicle;Hyperpigmentation of the skin (1 variants)
  • 6 conditions (1 variants)
  • 9 conditions (1 variants)
  • Familial Mediterranean fever, autosomal dominant;Familial Mediterranean fever (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MEFV gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
9
clinvar
220
clinvar
9
clinvar
238
missense
4
clinvar
5
clinvar
285
clinvar
13
clinvar
5
clinvar
312
nonsense
2
clinvar
2
clinvar
12
clinvar
2
clinvar
18
start loss
1
clinvar
1
frameshift
1
clinvar
3
clinvar
18
clinvar
1
clinvar
23
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
7
clinvar
7
splice region
5
17
1
23
non coding
34
clinvar
67
clinvar
19
clinvar
120
Total 7 10 367 303 33

Highest pathogenic variant AF is 0.0000525

Variants in MEFV

This is a list of pathogenic ClinVar variants found in the MEFV region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-3242045-T-A Familial Mediterranean fever Uncertain significance (Jan 13, 2018)885766
16-3242061-T-C Familial Mediterranean fever Uncertain significance (Jan 13, 2018)319085
16-3242085-C-A Familial Mediterranean fever Benign (Jan 13, 2018)319086
16-3242112-C-G Familial Mediterranean fever Uncertain significance (Jan 12, 2018)319087
16-3242133-T-C Familial Mediterranean fever Uncertain significance (Jan 12, 2018)886768
16-3242139-C-G Familial Mediterranean fever Uncertain significance (Jan 13, 2018)886769
16-3242160-T-C Familial Mediterranean fever Uncertain significance (Jan 13, 2018)886770
16-3242182-A-G Familial Mediterranean fever Uncertain significance (Jan 12, 2018)886771
16-3242279-T-G Familial Mediterranean fever Uncertain significance (Jan 13, 2018)886772
16-3242296-G-A Familial Mediterranean fever Uncertain significance (Jan 12, 2018)886773
16-3242304-C-CAGT Familial Mediterranean fever Likely benign (Jun 14, 2016)319088
16-3242323-T-G Familial Mediterranean fever Uncertain significance (Jan 12, 2018)319089
16-3242344-A-G Familial Mediterranean fever Uncertain significance (Jan 13, 2018)888047
16-3242361-CA-C Familial Mediterranean fever Uncertain significance (Jun 14, 2016)319090
16-3242379-AG-A Familial Mediterranean fever Uncertain significance (Jun 14, 2016)319091
16-3242380-G-C Familial Mediterranean fever Uncertain significance (Jan 13, 2018)888048
16-3242398-A-G Familial Mediterranean fever Benign (Jan 12, 2018)319092
16-3242417-C-T Familial Mediterranean fever Uncertain significance (Jan 13, 2018)319093
16-3242420-A-T Familial Mediterranean fever Uncertain significance (Jan 13, 2018)888049
16-3242440-C-T Familial Mediterranean fever Uncertain significance (Jan 12, 2018)319094
16-3242446-G-C Familial Mediterranean fever Uncertain significance (Jan 13, 2018)888050
16-3242451-C-A Familial Mediterranean fever Uncertain significance (Jan 13, 2018)884919
16-3242462-G-C Familial Mediterranean fever Uncertain significance (Jan 13, 2018)319095
16-3242502-C-T Familial Mediterranean fever Uncertain significance (Jan 13, 2018)319096
16-3242562-G-T Familial Mediterranean fever Uncertain significance (Jan 13, 2018)884920

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MEFVprotein_codingprotein_codingENST00000219596 1014600
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.02e-140.1391257000481257480.000191
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.725514491.230.00002885003
Missense in Polyphen120108.871.10221441
Synonymous-2.502421971.230.00001361600
Loss of Function0.9862530.90.8090.00000149374

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006890.000689
Ashkenazi Jewish0.000.00
East Asian0.0003260.000326
Finnish0.000.00
European (Non-Finnish)0.00009730.0000879
Middle Eastern0.0003260.000326
South Asian0.0004900.000490
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the regulation of innate immunity and the inflammatory response in response to IFNG/IFN-gamma. Organizes autophagic machinery by serving as a platform for the assembly of ULK1, Beclin 1/BECN1, ATG16L1, and ATG8 family members and recognizes specific autophagy targets, thus coordinating target recognition with assembly of the autophagic apparatus and initiation of autophagy. Acts as an autophagy receptor for the degradation of several inflammasome components, including CASP1, NLRP1 and NLRP3, hence preventing excessive IL1B- and IL18- mediated inflammation (PubMed:16785446, PubMed:17431422, PubMed:26347139). However, it may also have a positive effect in the inflammatory pathway. In different experimental systems, it has been shown to activate IL1B production (PubMed:16037825). It has also been shown to be required for PSTPIP1-induced PYCARD oligomerization and for formation of inflammasomes. Recruits PSTPIP1 to inflammasomes, and is required for PSTPIP1 oligomerization (PubMed:10807793, PubMed:11468188, PubMed:17964261, PubMed:18577712, PubMed:19109554, PubMed:19584923). {ECO:0000269|PubMed:10807793, ECO:0000269|PubMed:11468188, ECO:0000269|PubMed:16037825, ECO:0000269|PubMed:16785446, ECO:0000269|PubMed:17431422, ECO:0000269|PubMed:17964261, ECO:0000269|PubMed:18577712, ECO:0000269|PubMed:19109554, ECO:0000269|PubMed:19584923, ECO:0000269|PubMed:26347139}.;
Disease
DISEASE: Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]: A hereditary periodic fever syndrome characterized by recurrent episodic fever, serosal inflammation and pain in the abdomen, chest or joints. It is frequently complicated by reactive amyloidosis, which leads to renal failure and can be prophylactically treated with colchicine. {ECO:0000269|PubMed:10024914, ECO:0000269|PubMed:10090880, ECO:0000269|PubMed:10234504, ECO:0000269|PubMed:10364520, ECO:0000269|PubMed:10612841, ECO:0000269|PubMed:10842288, ECO:0000269|PubMed:10854105, ECO:0000269|PubMed:11470495, ECO:0000269|PubMed:15024744, ECO:0000269|PubMed:16378925, ECO:0000269|PubMed:16730661, ECO:0000269|PubMed:23031807, ECO:0000269|PubMed:24929125, ECO:0000269|PubMed:26347139, ECO:0000269|PubMed:9288094, ECO:0000269|PubMed:9288758, ECO:0000269|PubMed:9668175}. Note=The disease is caused by mutations affecting the gene represented in this entry. The disease-associated mutations in the B30.2/SPRY domain perturb ULK1 recruitment and autophagic degradation of inflammasome components, including NLRP3, and hence may contribute to the inflammatory phenotype associated with ARFMF. {ECO:0000269|PubMed:26347139}.; DISEASE: Familial Mediterranean fever, autosomal dominant (ADFMF) [MIM:134610]: A hereditary periodic fever syndrome characterized by periodic fever, serosal inflammation and pain in the abdomen, chest or joints as seen also in the autosomal recessive form of the disease. It is associated with reactive renal amyloidosis and characterized by colchicine unresponsiveness. {ECO:0000269|PubMed:10787449, ECO:0000269|PubMed:14679589}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
NOD-like receptor signaling pathway - Homo sapiens (human);Nucleotide-binding Oligomerization Domain (NOD) pathway;The NLRP3 inflammasome;Inflammasomes;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Innate Immune System;Immune System (Consensus)

Recessive Scores

pRec
0.214

Intolerance Scores

loftool
0.912
rvis_EVS
1.19
rvis_percentile_EVS
92.85

Haploinsufficiency Scores

pHI
0.0876
hipred
N
hipred_score
0.112
ghis
0.460

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.428

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mefv
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; skeleton phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype;

Gene ontology

Biological process
inflammatory response;positive regulation of autophagy;negative regulation of interleukin-1 beta production;negative regulation of interleukin-12 production;response to interferon-gamma;negative regulation of inflammatory response;negative regulation of macrophage inflammatory protein 1 alpha production;negative regulation of cytokine production involved in inflammatory response;negative regulation of NLRP3 inflammasome complex assembly;positive regulation of cysteine-type endopeptidase activity
Cellular component
ruffle;nucleus;cytoplasm;autophagosome;cytosol;microtubule;microtubule associated complex;lamellipodium;cytoplasmic vesicle
Molecular function
actin binding;protein binding;zinc ion binding;identical protein binding